[1] |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015 [J]. CA Cancer J Clin, 2016, 66(2):115-132.
|
[2] |
Gewinner C, Wang ZC, Richardson A, et al. Evidence that inositol polyphosphate 4-phosphatase type Ⅱ is a tumor suppressor that inhibits PI3K signaling [J]. Cancer Cell, 2009, 16(2):115-125.
|
[3] |
Fedele CG, Ooms LM, Ho M, et al. Inositol polyphosphate 4-phosphatase Ⅱ regulates PI3K/Akt signaling and is lost in human basal-like breast cancers [J]. Proc Natl Acad Sci U S A, 2010, 107(51):22231-22236.
|
[4] |
Hodgson MC, Shao LJ, Frolov A, et al. Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer [J]. Cancer Res, 2011, 71(2):572-582.
|
[5] |
胡勤龙,王红兵,杨明. INPP4B基因在胃癌组织中的表达及意义[J]. 世界华人消化杂志, 2016, 24(16):2478-2484.
|
[6] |
Kofuji S, Kimura H, Nakanishi H, et al. INPP4B is a PtdIns (3, 4, 5)P3 phosphatase that can act as a tumor suppressor [J]. Cancer Discov, 2015, 5(7):730-739.
|
[7] |
Woolley JF, Dzneladze I, Salmena L. Phosphoinositide signaling in cancer: INPP4B Akt(s) out [J]. Trends Mol Med, 2015, 21(9):530-532.
|
[8] |
Agoulnik IU, Hodgson MC, Bowden WA, et al. INPP4B: the new kid on the PI3K block [J]. Oncotarget, 2011, 2(4):321-328.
|
[9] |
Gasser JA, Inuzuka H, Lau AW, et al. SGK3 Mediates INPP4B-Dependent PI3K Signaling in Breast Cancer [J]. Mol Cell, 2014, 56(4):595-607.
|
[10] |
Christian R. INPP4B, a new player in the chemoresistance of AML [J]. Blood, 2015, 125(8):2738-2749.
|
[11] |
Dzneladze I, He R, Woolley JF, et al. INPP4B overexpression is associated with poor clinical outcome and therapy resistance in acute myeloid leukemia [J]. Leukemia, 2015, 29(7):1485-1495.
|
[12] |
Guo ST, Chi MN, Yang RH, et al. INPP4B is an oncogenic regulator in human colon cancer [J]. Oncogene, 2016, 35(23):3049-3061.
|
[13] |
黄常志,孙晓杰. P13 K-A kt信号通路与肿瘤 [J]. 世界华人杂志, 2006, 21(7):306-311.
|
[14] |
Κonstantia T, Stratigoula ES, Georgia L, et al. Immunohistochemical and molecular analysis of PI3K/AKT/mTOR pathway in esophageal carcinoma [J]. APMIS, 2015, 123(8):639-647.
|
[15] |
Li B, Cheung PY, Wang X, et al. Id-1 activation of PI3K/Akt/NFkappaB signaling pathway and its significance in promoting survival of esophageal cancer cells [J]. Carcinogenesis, 2007, 28(11):2313-2320.
|
[16] |
Takahashi K, Miyashita M, Makino H, et al. Expression of Akt and Mdm2 in human esophageal squamous cell carcinoma [J]. Exp Mol Pathol, 2009, 87(1):42-47.
|
[17] |
Yoshioka A, Miyata H, Doki Y, et al. The activation of Akt during preoperative chemotherapy for esophageal cancer correlates with poor prognosis [J]. Oncol Rep, 2008, 19(5):1099-1107.
|
[18] |
Chi MN, Guo ST, Wilmott JS, et al. INPP4B is upregulated and functions as an oncogenic driver through SGK3 in a subset of melanomas [J]. Oncotarget, 2015, 6(37):39891-39907.
|